// App-Quantinova.ai

3493 : New, highly potent antibodies to death receptors having Fc mutations to increase antitumor activity

Researchers

Presenter

  • Lihong Wang

Principal Investigators

  • Yi Ding

  • Hangil Park

  • April Zhang

  • Zhengran Wang

  • Maximiliano Vasquez

  • Cary Queen

  • Jin Kim

Medical Centers

  • Galaxy Biotech, LLC, Sunnyvale, CA.

Locations

  • United States

Companies

  • Galaxy Biotech, LLC

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Drozitumab

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved